These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 9568959)
1. Pseudotype formation with La Crosse virus glycoproteins. Bupp K; González-Scarano F J Gen Virol; 1998 Apr; 79 ( Pt 4)():667-71. PubMed ID: 9568959 [TBL] [Abstract][Full Text] [Related]
2. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. Pekosz A; Griot C; Stillmock K; Nathanson N; Gonzalez-Scarano F J Virol; 1995 Jun; 69(6):3475-81. PubMed ID: 7745694 [TBL] [Abstract][Full Text] [Related]
3. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism. Ma M; Kersten DB; Kamrud KI; Wool-Lewis RJ; Schmaljohn C; González-Scarano F Virus Res; 1999 Oct; 64(1):23-32. PubMed ID: 10500280 [TBL] [Abstract][Full Text] [Related]
4. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry. Plassmeyer ML; Soldan SS; Stachelek KM; Martín-García J; González-Scarano F Virology; 2005 Jul; 338(1):121-32. PubMed ID: 15923017 [TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection. Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251 [TBL] [Abstract][Full Text] [Related]
7. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment. Papaneri AB; Wirblich C; Marissen WE; Schnell MJ Vaccine; 2013 Dec; 31(49):5897-902. PubMed ID: 24120673 [TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666 [TBL] [Abstract][Full Text] [Related]
9. Production, characterization, and utility of monoclonal antibodies which react with a novel chimeric glycoprotein of human respiratory syncytial virus termed FG. Brideau RJ; Walters RR; Wathen MW Hybridoma; 1989 Dec; 8(6):623-9. PubMed ID: 2613268 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of monoclonal antibodies directed against glycoproteins of bovine leukaemia virus. Orlík O; Bán J; Gieciová E; Altanerová V; Altaner C Acta Virol; 1993 Oct; 37(5):377-87. PubMed ID: 8184790 [TBL] [Abstract][Full Text] [Related]
11. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity. Grady LJ; Kinch W J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against La Crosse virus. Grady LJ; Srihongse S; Grayson MA; Deibel R J Gen Virol; 1983 Aug; 64 (Pt 8)():1699-704. PubMed ID: 6192204 [TBL] [Abstract][Full Text] [Related]
13. Structure and biological function of La Crosse G1 glycoprotein. Kingsford L Prog Clin Biol Res; 1983; 123():157-66. PubMed ID: 6191342 [No Abstract] [Full Text] [Related]
14. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity in mice of human metapneumovirus with a truncated SH glycoprotein. Tedcastle AB; Fenwick F; Robinson MJ; Toms GL J Med Virol; 2014 Apr; 86(4):547-57. PubMed ID: 24009128 [TBL] [Abstract][Full Text] [Related]
16. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates. Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135 [TBL] [Abstract][Full Text] [Related]
17. Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Jacoby DR; Cooke C; Prabakaran I; Boland J; Nathanson N; Gonzalez-Scarano F Virology; 1993 Apr; 193(2):993-6. PubMed ID: 8460503 [TBL] [Abstract][Full Text] [Related]
18. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. Balasuriya UB; Maclachlan NJ; De Vries AA; Rossitto PV; Rottier PJ Virology; 1995 Mar; 207(2):518-27. PubMed ID: 7533965 [TBL] [Abstract][Full Text] [Related]
19. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization. Kingsford L; Hill DW J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863 [TBL] [Abstract][Full Text] [Related]
20. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Lefrancios L; Lyles DS Virology; 1982 Aug; 121(1):157-67. PubMed ID: 6180550 [No Abstract] [Full Text] [Related] [Next] [New Search]